Skip to main content
. 2015 Nov 18;6:575. doi: 10.3389/fimmu.2015.00575

Figure 6.

Figure 6

VitD-CD11c + BMDC can effectively prime T cells in vivo. B10.PLxC57BL/6 mice received 2 × 106 Tg4.CD45.1 CD4+ T cells 1 day prior to s/c injection of 1 × 105 MBP-loaded CD11c+ Veh-BMDC or CD11c+ VitD-BMDC into the hindlimb. Six days later, spleen and draining lymph nodes were harvested for FACS analysis of total CD4+ and donor CD45.1+ cells. The total numbers of cells, number of donor Tg4 cells, percentage of donor Tg4 cells of total CD4+ cells, percentage of Ki67+ of donor Tg4 cells, and percentage of GM-CSF+ donor Tg4 are shown in spleen and DLN. Data are from one of two experiments giving consistent results.